logo

Welcome to Soundbite Medical

SoundBite Medical is a medical devices start-up that started Operations in May 2015, with its R&D facilities in Sherbrooke and commercialization headquarters in Montreal, Quebec.
Working Hours
Monday - Friday 09:00AM - 17:00PM
Saturday - Sunday CLOSED

+1 (514) 956-2525

2300 Alfred Nobel, Suite 230, Montreal, QC, H4S 2A4, Canada

Top

Motivation

Soundbite medical / Motivation

SoundBite announces new CEO

MONTREAL, July 28 2017 – SoundBite Medical Solutions Inc. (SBMS), a Montreal-based cardiovascular medical technology company, is pleased to announce that Martin Brouillette, Co-Founder and Chief Technology Officer, has been named Chief Executive Officer. Martin is the one of the inventors of Soundbite’s proprietary technology and has been instrumental in all aspects of the company's development to date including the recent First-in-Human trial. Martin has also spearheaded pre-clinical developments, driven the widening of the company’s products portfolio and was a key player in Soundbite’s very successful $15M Seed Round financing. Martin will lead SoundBite to maximize its potential in developing not only treatments for interventional vascular care but also in the much larger field of vessel preparation, leveraging his strong technical expertise and leadership. He succeeds...

Share

SoundBite Announces the Hiring of Abder Benrabah to the position of Vice-President, Quality Engineering and Assurance

MONTREAL, March 1st, 2017 – SoundBite Medical Solutions Inc. (SBMS Inc.), a Montreal-based cardiovascular (CV) medical technology company, is pleased to announce its recent hire of Abder Benrabah, an industry Quality Assurance (QA) and Regulatory Affairs (RA) leader in medical devices. Mr. Benrabah will join the SBMS team as Vice-President Quality Engineering and Assurance, to lead the quality function of SoundBite’s shockwave technology in the exciting and challenging arena of chronic total occlusions (CTOs) of the cardiovascular system. Mr. Benrabah brings over twenty-six years of leadership experience in various fields, including medical devices. He has held various management positions in QA, RA and Continuous Improvement at CryoCath Technologies, Biorthex Inc. & PerkinElmer BioSignal. Abder joins SBMS Inc. from Smith & Nephew Inc. where he...

Share

SoundBite Initiates Human Clinical Studies for Peripheral CTO Crossing Procedures

MONTREAL – December 6th, 2016 – SoundBite Medical Solutions Inc. (SBMS) announced today that it has performed its First-In-Human (FIH) procedure using shockwave energy to successfully and safely cross a chronic total occlusion (CTO). The 72-year-old male patient had bilateral superficial femoral artery occlusions (both over 20 cm in length) in the legs, leading to incapacitating claudication and unfavorable quality of life. Dr. Andrew Benko, performed the minimally invasive procedure using a .018” guidewire (ShockWire™) that delivered high energy shockwaves into the patient’s arteries to completely cross both occlusions including several calcified nodules and re-establish blood flow. In up to 30% of cases, these type of occlusions could be difficult and sometimes impossible to cross, resulting in a need for surgical intervention and potentially amputation. ...

Share
q

SoundBite Announces a New Financing

Montreal, Canada - October 31st 2016 - SoundBite Medical Solutions Inc. (SBMS), a Montreal and Sherbrooke-based cardiovascular medical technology company, announced today the third closing of the seed equity round for $5 million. The financing was co-led by new Canadian investors Accel-Rx Health Sciences Accelerator, BDC Capital and the Bertrand group. “This third and final closing of our Seed Equity Round is further evidence of the strong interest SoundBite’s technology and business model have generated in the financial community” says Francis Bellido, CFO of SBMS Inc. This new financing brings the total cash proceeds from all the financings to $14 million. These funds will be used to accelerate our clinical development plan for our pivotal trial and prepare for a...

Share

Soundbite Medical Solutions Inc. Announces Latest Financing in Seed Round

MONTREAL, May 19, 2016 – SoundBite Medical Solutions Inc. (SBMS Inc.), a Montreal and Sherbrooke-based cardiovascular (CV) medical technology company, announced today the first closing of the seed equity round for $6 million. The financing was co-led by new investors Med-Innov from France and Karsh Holdings from Toronto. “I am very encouraged by the interest and financial support shown at the local and international level, among angels and many cardiovascular stakeholders, who all have contributed to this very successful year of financing”, says Francis Bellido, CFO of SBMS Inc. Including the conversion of the 2 convertible debenture financings in 2015, and the anticipated 2nd and final closing of the seed equity round in June 2016, it is expected that the total raise will be $10.0 million. This...

Share

Soundbite Medical Solutions Inc. Announces new leadership: Chief Product Development Officer

MONTREAL, May 26, 2016 – SoundBite Medical Solutions Inc. (SBMS Inc.), a Montreal-based cardiovascular (CV) medical technology company, announced today the hiring of Mr. Marwan Abboud, an industry R&D leader in CV medical devices, to spearhead the final stages of development and commercialization of SoundBite shockwave technology in the exciting and challenging arena of chronic total occlusions (CTO’s) of the cardiovascular system. Mr. Abboud brings over twenty three years of R&D leadership experience in CV product development. He championed R&D, at CryoCath Technologies, from 1995 to 2008, where he completed his mandate as VP, R&D. Marwan led the innovation process at CryoCath, a catheter cryoablation technology for the treatment of atrial fibrillation (AF). His name is on over one hundred and forty-eight issued US patents and...

Share
q

Announcement

I am pleased to announce the following organizational enhancements at Soundbite Medical Solutions: -Dr. Martin Brouillette, (PEng), Inventor and Co-Founder of Soundbite, as the Chief Technology Officer, will lead all current and future scientific and technology development activities. In this capacity, Mr. Louis-Philippe Riel, Scientific Development Engineer, will report directly to Dr Brouillette. -Dr Harold Wodlinger (PEng) has agreed to join the Company as VP Product Development and lead the overall product development activities, effective immediately. In this role, both Mr. Steven Dion, Product Design Engineer, and Mr. Wayne Cornish, Head of Wire Design and Development, will report directly to Dr Wodlinger. -Mr. Klaus Kepper, CPA, MBA, has accepted the role as External CFO of Soundbite, effective April 1, 2015. It is expected that Mr. Kepper’s role will...

Share